All stock lists
Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
Healthcare · Drug Manufacturers - Specialty & Generic
27.41-0.30 (-1.08%)
Insider Score
––Not scored
HIMS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
HIMS analyst forecast
HIMS analyst consensus
Hold8 ratings
Buy 2 Hold 6 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
HIMS 12-month price target
$27.83+1.5% upsideaverage of 6 firms
$42.00High
$18.00Low
Best analysts covering HIMS
- B of A Securities92%success rate · 13 calls
- Citigroup78%success rate · 9 calls
- Canaccord Genuity60%success rate · 5 calls
- Needham25%success rate · 4 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
HIMS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Truist Securities | Hold | — | — | Reiterated | 2026-08-24 |
| Barclays | Overweight | $35.00 | +6.6% | Reiterated | 2026-08-21 | |
| Deutsche Bank | Hold | $26.00 | -16.7% | Reiterated | 2026-08-11 | |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-08-11 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-08-11 |
| Needham | Buy | $42.00 | +32.2% | Reiterated | 2026-08-11 | |
| — | Morgan Stanley | Equal Weight | — | — | Reiterated | 2026-08-11 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-08-11 |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-07-24 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-07-23 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-07-09 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-07-01 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-07-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-06-18 |
| Leerink Partners | — | $25.00 | -9.5% | — | 2026-06-02 | |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-05-26 |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-05-22 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-05-19 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-05-13 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-05-12 |
| — | BTIG | Neutral | — | — | Reiterated | 2026-05-12 |
| — | Needham | Buy | — | — | Reiterated | 2026-05-12 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-05-12 |
| Deutsche Bank | — | $25.00 | -4.5% | — | 2026-05-05 | |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-04-24 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2026-04-16 |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-03-27 |
| — | Leerink Partners | Market Perform | — | — | Reiterated | 2026-03-16 |
| — | Barclays | Overweight | — | — | Reiterated | 2026-03-11 |
| — | Deutsche Bank | Hold | — | — | Reiterated | 2026-03-10 |
| — | B of A Securities | Neutral | — | — | Upgraded | 2026-03-10 |
| — | Citigroup | Neutral | — | — | Upgraded | 2026-03-10 |
| Needham | Buy | $30.00 | +34.2% | Upgraded | 2026-03-09 | |
| — | Barclays | Overweight | — | — | Reiterated | 2026-02-25 |
| Morgan Stanley | Equal Weight | $21.00 | +46.0% | Reiterated | 2026-02-25 | |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-02-24 |
| — | Truist Securities | Hold | — | — | Reiterated | 2026-02-24 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2026-02-24 |
| — | BTIG | Neutral | — | — | Downgraded | 2026-02-24 |
| — | Leerink Partners | Market Perform | — | — | Reiterated | 2026-02-24 |
| — | Citigroup | Sell | — | — | Reiterated | 2026-02-24 |
| Truist Financial | — | $18.00 | +16.1% | — | 2026-02-24 | |
| Deutsche Bank | — | $31.00 | +69.8% | — | 2026-02-10 | |
| — | TD Cowen | Hold | — | — | Reiterated | 2026-02-09 |
| — | B of A Securities | Underperform | — | — | Reiterated | 2026-02-09 |
| — | Citigroup | Sell | — | — | Reiterated | 2026-02-09 |
| Leerink Partners | — | $20.00 | +15.3% | — | 2026-02-09 | |
| — | BTIG | Buy | — | — | Reiterated | 2026-02-02 |
| Leerink Partners | — | $41.00 | +1.9% | — | 2025-12-04 | |
| Morgan Stanley | — | $40.00 | +0.6% | — | 2025-11-12 | |
| — | BTIG | Buy | — | — | Reiterated | 2025-11-04 |
| — | B of A Securities | Underperform | — | — | Reiterated | 2025-11-04 |
| Truist Financial | — | $37.00 | -17.3% | — | 2025-11-04 | |
| Leerink Partners | — | $46.00 | +3.6% | — | 2025-11-04 | |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-09-12 |
| — | Truist Securities | Hold | — | — | Reiterated | 2025-08-18 |
| — | Needham | Hold | — | — | Reiterated | 2025-08-05 |
| — | Truist Securities | Hold | — | — | Reiterated | 2025-07-17 |
HIMS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-23 | 0.02 | 0.07 | $619.2M | $617.8M |
| 2026-05-11 | 0.03 | -0.40 | $616.8M | $608.1M |
| 2026-08-10 | -0.05 | -0.37 | $698.9M | $753.2M |
| 2026-11-09 | 0.06 | 0.00 | $892.9M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.